Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Go back to Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update| (NASDAQ: NRIX) | Delayed: 19.00 +0.35 (1.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.65 | 52 Week High | $ | |||
| Open | $18.49 | 52 Week Low | $ | |||
| Day High | $19.08 | P/E | N/A | |||
| Day Low | $18.39 | EPS | $ | |||
| Volume | 509,270 | |||||

